Repeat-Dose Pharmacokinetics and Pharmacodynamics of Bortezomib in Patients With Relapsed Multiple Myeloma

This study has been completed.

Study NCT00080405 Information provided by Millennium Pharmaceuticals, Inc.

First Received: March 30, 2004 Last Updated: March 26, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	June 2005 (Final data collection date for primary outcome measure)